Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

UV radiation may cause DNA changes in skin, certain UVB therapy helps psoriasis, a new gene mutation is linked to mild piebaldism, different immune cells affect psoriasis, a drug promotes hair growth, and some cancer drugs could treat skin barrier issues.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

SIG-1451 could be a promising new treatment for atopic dermatitis.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Tofacitinib can help regrow hair in about 50% of people with moderate-severe alopecia areata.

Tectona grandis leaf extracts, especially with propylene glycol, may be promising for topical hair loss treatments.

Baricitinib successfully treated severe hair loss.

Some blood pressure medications are linked to a higher risk of skin cancer.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

No cure exists for alopecia areata, and treatments are personalized.

IL-15 helps hair grow longer and stronger by extending the growth phase and reducing cell death.

Norgalanthamine helps hair cells grow by activating certain pathways related to hair growth.

Astragalus membranaceus helps regrow hair and reduce hair loss symptoms.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Anti-IL-1 treatments might help with certain types of hair loss in people with high inflammation.

TPA promotes hair growth by increasing stem cell activity and activating specific cell signals.

Tsukushi helps control inflammation and aids in wound healing.

Activating TRPV3 channels stops hair growth by killing hair follicle cells.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Low-dose bisphenol A increases prostate size in rats by affecting certain enzymes.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.